Tag: Motley Fool

  • Why the Universal (ASX:UBI) share price reached a multi-year high today

    2 businessmen shaking hands

    The Universal Biosensors, Inc. (ASX: UBI) share price reached a multi-year high of 50 cents today. This comes as the company announced a new distribution agreement with Grapeworks Pty Ltd.

    Its high was short lived, however, with the Universal share price pulling back to 46.5 cents, down 5.1% at the time of writing. In comparison, the All Ordinaries Index has remained positive all day, treading at 6,908 points, up 06%.

    Distribution agreement

    The Universal share price has backflipped from its multi-year high, despite an upbeat announcement.

    In today’s release, Universal advised it has signed an exclusive distribution agreement with Grapeworks for the Australian market. The partnership will exist for 5 years, with standard renewal and termination options available to both parties.

    Grapeworks provides beverage makers a range of winemaking, cider and brewing consumables and supplies. The company specialises in high-end bottle packaging and closures.

    In other news today, Universal revealed it has launched a dedicated website page for its Sentia product, a digital wine analyser. The company anticipates this will support the sales and promotion of the new offering.

    What did management say?

    Commenting on the launch, Universal CEO John Sharman said:

    The launch of Sentia represents UBI’s first new product in almost 7 years and leverages UBI’s core biosensor platform technology. We believe Sentia has the potential to change the way wine testing is performed globally.

    Grapeworks is Australia’s leading wine supply company offering a complete range of production equipment, winemaking, cider and brewing consumables and supplies. We are delighted to partner with Grapeworks who have shown their confidence in the future of Sentia with a first order for product worth more than $300,000.

    Grapeworks managing director Malcom Wilson added:

    Sentia offers a unique solution for winemakers and we are pleased to be Australia’s exclusive distributor. We are excited by the prospect of selling Sentia and believe the future testing capability for glucose, fructose, and malic acid will add significant value to the winemaking industry in Australia and around the world.

    About the Universal share price

    The Universal share price has been a strong performer since the beginning of the year, rising 156%. Although lower at the time of writing, the Universal share price hit a multi-year high of 50 cents today.

    Universal has a market capitalisation of $84.3 million.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Universal (ASX:UBI) share price reached a multi-year high today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3ggXRgf

  • 3 stellar ASX growth shares to buy

    A happy woman pointing to her big smile, indicating a surge in share price

    The Australian share market is home to a large number of companies that have been growing at a strong rate in recent years.

    Three that have been tipped to continue this positive form are listed below. Here’s why they could be top options for growth investors:

    Appen Ltd (ASX: APX)

    Appen is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). It has team of over a million contractors spread out across the world preparing or creating the data for the machine learning models of some of the world’s largest companies and government agencies. Due to favourable industry tailwinds, analysts at Morgan Stanley believe it has strong long term growth potential. They recently put an overweight rating and $40.00 price target on its shares.

    NEXTDC Ltd (ASX: NXT)

    NEXTDC is one of the region’s leading data centre operators. It has been delivering strong revenue and operating earnings growth in recent years thanks to increasing demand for capacity in its centres. The catalyst for this has been the structural shift to the cloud, which has accelerated during the pandemic. One broker that is very positive on its future is Goldman Sachs. It recently reiterated its buy rating and $13.20 price target on its shares. The broker even suggested the NEXTDC share price could go to $20.00 based on high but not unrealistic assumptions.

    ResMed Inc. (ASX: RMD)

    ResMed is a medical device company which has been growing at a consistently strong rate over the last decade. This has been underpinned by its industry-leading sleep treatment products and its growing market opportunity. Pleasingly for shareholders, its market is still growing strongly. Management believes there are upwards of a billion people suffering from sleep apnoea globally. As more and more become aware of the disorder and seek treatment, the company is in a strong position to benefit. Analysts at Morgans are positive on its outlook. They have an add rating and $30.99 price target on its shares.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Appen Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 3 stellar ASX growth shares to buy appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2JTIqOP

  • Here’s why the Beach Energy (ASX: BPT) share price is up more than 50% over the past month

    asx share price rise represented by red paper plane flying away from other white paper planes

    The Beach Energy Ltd (ASX: BPT) share price is up 1.07% at the time of writing today to $1.89 a share. That doesn’t sound too impressive on its own, but consider this: Beach shares are now up more than 51% over the past month alone.

    In fact, since 2 November, the Beach share price is up an extraordinary 64.3%, making it one of the best performers on the S&P/ASX 200 Index (ASX: XJO) in the month of November.

    So what’s going on here to prompt such enthusiastic buying pressure?

    Beach shares surf an oil wave

    There are only two likely reasons why Beach shares have performed the way they have over the past month or so: higher oil prices and the expectation of even higher oil prices.

    Since late October, the price of Brent crude oil has climbed from under US$38 a barrel to the current level (according to Bloomberg) of US$49 a barrel. That’s a rise of close to 30% in just over a month. It’s also the highest level crude oil has traded at since early March, when the oil market was in freefall due to the unfolding coronavirus pandemic.

    So we can establish rising oil prices are a factor here. But what of sentiment?

    Where is oil going next?

    Many commentators are predicting that oil hasn’t finished climbing just yet. A broker note from Goldman Sachs last month shows the investment bank is pricing in oil at US$50–$55 a barrel in 2021.

    Another investment bank is even more bullish. As my Fool colleague Brendon Lau covered last month, Credit Suisse reckons that Brent crude could go as high as US$196 a barrel next year, depending on whether the Organization of the Petroleum Exporting Countries (OPEC) decides to maintain agreed cuts in oil production. Even if OPEC relaxes production to pre-pandemic levels, Credit Suisse still sees oil at US$80 a barrel, with US$65 a barrel a base case scenario.

    These predictions are still just predictions, and depend a great deal on external factors, such as the rollout of a successful coronavirus vaccine candidate, and rebounds in economic growth across the global economy. But even so, it seems things are looking up for oil overall.

    That’s likely the reasons behind this company’s stellar share price performance over the past month or so. We can also see similar performances from other ASX oil companies like Woodside Petroleum Ltd (ASX: WPL) and Oil Search Ltd (ASX: OSH), which lends credence to this thesis.

    Looking For Bargain Buys? These Cheap Stocks Could Be Just What You’re After (FREE REPORT)

    Scott Phillips has released a FREE stock report revealing 5 stocks that he believes are WAY undervalued by the market at these current prices.

    Scott thinks these 5 stocks are a ‘must consider’ for any savvy investor.

    Don’t miss out! Simply click the link below to grab your free copy and discover Scott’s 5 bargain stocks now.

    Click Here For Your Free Stock Report

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Here’s why the Beach Energy (ASX: BPT) share price is up more than 50% over the past month appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3lNt4bN

  • The sector that’ll explode in February: fundie

    Profile picture of Dermot Ryan from AMP Capital

    Ask A Fund Manager

    The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, AMP Ltd (ASX: AMP) portfolio manager Dermot Ryan reveals which sector he thinks is way too overvalued and which one is ripe for a rally.

    The Motley Fool: What’s your fund’s philosophy?

    Dermot Ryan: We’re a tax-aware income manager that manages money for retirees and accumulators in Australia, who can benefit from banking credits and high levels of dividends.

    MF: Even though you’re income-focused, do you invest in all types of shares to get that outcome — or are you purely focused on dividend stocks?

    DR: We take a cyclical approach to the market. So in times where we think the market is overbought, we’re in more defensive stocks — stocks with strong balance sheets and very defendable dividends.

    But in downturns we will buy growth stocks if they become cheap enough and we can start to see the earnings profile. Also stocks that are able to bring through cash flow, or indeed stocks that have cut their dividends and we think, well over the mid cycle they’ll re-establish their dividends. 

    So we do buy growth stocks, which is a bit unusual for an income manager, but it’s an area where we deliver a lot of alpha relative to our peers.

    The trick with being an income manager is to manage both the capital and the income. A lot of people look at a high dividend yield, but the income may be higher because it’s not sustainable. And ultimately the capital value of that investment can drop over time.

    COVID-19 crash 

    MF: How has COVID-19 affected the fund?

    DR: COVID-19 has presented a lot of opportunities in the market. We were quite defensively positioned at the start of the year, because we weren’t seeing a lot of earnings growth in the market. 

    Then we saw the lockdowns rolling through first Asia and then Europe. We recognised early that the lockdowns were going to have a very large impact on dividends, and so we were able to position out of a lot of stocks that had dividend exposure to the lockdowns. 

    During the end of quarter one, we were able to rotate into some cyclical positions.

    Through quarter two and later in the year, we’ve benefited from buying a lot of reopening shares, participating in a lot of capital raisings. And positioning the funds to benefit at the cycle. 

    Buying and selling 

    MF: What do you look at closely when considering buying a stock?

    DR: We look at what the future cash flow of the business was going to be, and we look at that versus our estimate of what the value of that business will be on a mid cycle basis.

    MF: What triggers you to sell a share?

    DR: Again, if we think a stock is about to cut its dividend, or business conditions for that stock in its industry are changing to a point where they cut its dividends, or they’re indeed just too expensive. 

    That’s the growth side of the portfolio — if the stocks become too expensive and their yield becomes too low, we’ll sometimes take profits off those growth positions.

    What’s coming up?

    MF: Where do you think the world is heading at the moment?

    DR: With a vaccine, the stage is set for a very positive environment for equities in 2021 and beyond. The reason is that equities provide one of the last risk premiums that are still historically attractive — given very low interest rates have reduced the expected returns in sectors such as fixed-income and other long-duration assets.

    MF: Eventually interest rates would have to go back up somewhat. Is there a risk of a bubble bursting?

    DR: Yes. As interest rates rise, it will cause problems for some asset classes, like property and infrastructure. In equities, if interest rates are rising it’s because growth is strong and maybe inflation is picking up. And that’s often good for equities because their earnings per share and the profits will actually grow with that inflation.

    It’s not a level playing field across the equity market, but in general, inflation is actually good for equities.

    Overrated and underrated shares

    MF: What’s your most underrated stock at the moment?

    DR: The underrated stock sector is Australian aged care. We think there’s some good opportunities in that space. The sector has gone through a very difficult year with COVID.

    However, the vaccine is coming and valuations are very undemanding and there are starting to be some corporate interests around the space. But more importantly, in February next year, the government’s going to announce its new funding package for that industry. 

    And we think that this could be a good catalyst for the industry as it positions into a new decade.

    MF: What do you think is the most overrated stock at the moment?

    DR: Buy-now, pay-later stock.

    MF: Ha ha, so I gather your fund doesn’t hold any Afterpay Ltd (ASX: APT) stocks, but can you elaborate?

    DR: We think it’s wonderful to have innovation and young, vibrant growing companies. However, it’s important as a stock market investor not to get carried away by growth and subscriber numbers. 

    Margins available in this space are starting out as high, but they’re being competed because there’s a number of different buy-now, pay-later players in the market. And we think it’s going to get more competitive. 

    We also think there are cryptocurrencies and blockchain solutions that can provide transactions at much lower levels than are currently being offered by the buy-now, pay-later players, or indeed the banks. 

    So we think longer term there’s going to be deflation in the amount of charges that the sector is able to charge to retailers or indeed clients. We’re bearish on the outlook for profits. We think at these levels, the sector has gone way too far.

    Looking back

    MF: Which stock are you most proud of from a past purchase?

    DR: Mineral Resources Limited (ASX: MIN). It’s a young domestic company. It’s only been in existence since the early 2000s. They do mining services — produce iron ore and lithium. And we’ve been investing in that stock for a while. It’s been a very strong performer.

    It gives very good exposure not just to iron ore, which [has high] margins but volumes have kind of peaked. And there’s some issues with potential exports to China, but we think it also gives good exposure to the lithium market, because they’ve got two very good lithium mines that happened recently, that they can deliver into the market over the next 2, 3 years.

    MF: Lithium is a good area to be in at the moment, isn’t it?

    DR: Yes. It’s a very interesting area given the amount of stimulus, and the amount of electric vehicle and industrial grid-scale batteries that are being put in place in Australia, Europe, the US, and China. It’s all over the world. 

    It’s a trend that could take off over the rest of the next decade as economies have to decarbonise. In fact, western countries for the first time in a long time have become a net importer of materials. So we’re quite excited about both the growth size and immature iron ore size, which is kind of a trade that’s a little bit older — maybe a last decade trade — but this stock has got a mixture of the two.

    MF: Has COVID-19 changed your investment methods going forward?

    DR: I think 2020 has been a microcosm of investing.

    We said to our clients back at the end of March, we thought that valuations had got to a point where you had to start buying into the market with cyclicals. We use the term “Buy to the sound of cannons”. That was a wonderful buying opportunity for retail investors in particular. 

    We think that as the confidence in the cycle builds, you’ll have to be a little bit more selective, particularly given the amount of excitement in the market now. You’ve got to be very careful, particularly in areas like buy-now, pay-later, where stocks have overrun fundamental evaluations.

    It really shows that you need to manage your emotions, you need to look at fundamental evaluations.

    You need to look for where the opportunities are, sometimes in the most dire of times. It’s been a volatile year. We’re looking forward to more normal years in the years ahead, but we’re quite confident and indeed excited about the environment offered to equities, given zero interest rates, ongoing stimulus and a global synchronised cycle.

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    Motley Fool contributor Tony Yoo owns shares of AFTERPAY T FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post The sector that’ll explode in February: fundie appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/36OHMLy

  • The Globe (ASX:GLB) share price rose 8%, smashed 52-week high today. Here’s why.

    The Globe International Limited (ASX: GLB) share price shot up to a 52-week high today after the company provided the first update since its annual general meeting (AGM) in October.

    In morning trade, shares in the sports and outdoor clothing company surged up 8% to a $2.65 high. The Globe share price has since retreated to $2.60, up 6.12%, at the time of writing.

    What did the company announce?

    Globe advised the market that its performance for the first-half of the 2021 financial year would be “significantly ahead” of the prior corresponding period, in both sales and profits.

    At its AGM on 22 October, Globe reported that it expected total group sales and profits to be ahead of last financial year based on the extremely strong first-quarter trade in FY21.

    Today, the company advised its strong first-quarter results had continued into the second quarter and it was in an extremely robust financial position with solid reserves of cash, and no debt.

    However, Globe did provide some caution today, saying that continued uncertainties relating to the COVID-19 pandemic, particularly in Europe and North America, made it impossible to give an accurate outlook for the full year of 2021. 

    What does Globe International do

    Globe International operates in the apparel business. It primarily produces and distributes purpose-built apparel including footwear, hardgoods for the board sports, street fashion, and work wear. It sells both proprietary and licensed brands.

    Some of its proprietary brands include Salty Crew, FXD, and Impala Skate. Meanwhile, Globe’s third-party business carries licensed brands such as Stussy, Obey, and Raen.

    About the Globe share price in 2020

    The Globe share price has lifted more than 60% so far in 2020. The share price was trading as low as $1.10 back in July before rebounding to today’s level, reaching its 52-week high.

    Globe International currently commands a market cap of $101 million.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Eddy Sunarto has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post The Globe (ASX:GLB) share price rose 8%, smashed 52-week high today. Here’s why. appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37JXaIa

  • The BHP (ASX:BHP) share price has just hit a multi-year high

    boost in mining asx share price represented by happy miner making fists with hands

    The BHP Group Ltd (ASX: BHP) share price was on form again on Monday.

    At one stage, the mining giant’s shares charged as much as 3% higher to a new multi-year high of $42.78.  

    When the BHP share price reached that level, it was up a sizeable 19% since this time last month.

    Why is the BHP share price at a multi-year high?

    Investors have been buying BHP’s shares over the last few weeks thanks to a rise in commodity prices.

    This appears to have positioned the Big Australian to deliver another bumper profit result in FY 2021.

    What has been happening?

    The first commodity of note is oil. Last week oil prices climbed higher again, which led to WTI and Brent prices recording their fifth consecutive week of gains. This bodes well for its petroleum operations.

    Also rising was copper. The base metal extended its year to date gain to over 24% last week, taking the price of the industrial metal to a seven-year high.

    But the commodity that is getting investors the most excited is iron ore. Given how much the steel-making ingredient contributes to BHP’s overall earnings, favourable iron ore prices are always good news for the mining giant.

    According to CommSec, on Friday the spot iron ore price jumped a further 5.4% to US$145.30 a tonne. This was driven by news that Vale has downgraded its production guidance, leading to concerns that supply could be constrained at a time when demand is robust.

    As a comparison, BHP has provided cost guidance of US$13 to US$14 a tonne for its iron ore operations. This means it will be generating significant free cash flow right now, which could lead to generous dividend payments next year.

    Is the BHP share price in the buy zone?

    It was largely because of this that this morning Macquarie retained its outperform rating and lifted its price target on BHP’s shares to $46.00.

    The broker has pencilled in a ~$2.78 per share fully franked dividend in FY 2021. Based on the current BHP share price, this equates to a 6.5% dividend yield.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post The BHP (ASX:BHP) share price has just hit a multi-year high appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37MAK9A

  • Is AGL (ASX:AGL) really offering a 7% dividend yield today?

    surprised asx investor appearing incredulous at hearing asx share price

    Looking at the AGL Energy Limited (ASX: AGL) share price today, a few things stand out. First up, the share price itself. AGL shares are trading at $13.46 at the time of writing. That gives this company a market capitalisation of $8.4 billion and a price-to-earnings (P/E) ratio of 8.51.

    That is a very low share price for AGL, historically speaking. The last time AGL shares were this low was back in early 2015. On these prices, AGL shares have lost more than 50% of their value since they hit $27.61 per share in 2017.

    And here’s another sobering statistic: you could have bought AGL shares for the same price as you can today, way back in 2006.

    But secondly, AGL’s trailing dividend appears to be offering a whopping 7.27% yield on today’s prices. That’s more than triple the trailing yield of 2.39% that market-wide S&P/ASX 200 Index (ASX: XJO) fund, iShares Core S&P/ASX 200 ETF (ASX: IOZ), is offering. And it’s over 13 times more yield than a Commonwealth Bank of Australia (ASX: CBA) term deposit is offering right now at 0.55% per annum.

    So is this yield too good to be true?

    The AGL monster dividend

    Well, let’s look at AGL’s latest shareholder payouts. Unlike some ASX dividend shares, AGL has paid two dividends in 2020. The first was an interim dividend of 47 cents per share (80% franked) that was paid in March. The second was a final dividend of 51 cents per share (also 80% franked), paid out in September. That’s 98 cents per share in dividends for 2020, giving AGL shares a trailing yield of 7.27%. So it does check out! Including the value of those franking credits, this trailing yield rises to 9.76% grossed-up.

    It is worth noting that AGL has given some rare guidance into its plans for this dividend over the next few years. The company currently has a ‘payout ratio’ policy, which instructs that 75% of its profits should be paid out as dividends every year. Back in August, AGL told investors that its profits for the 2020 financial year were $816 million, which was down 22% from the prior year. But it also told the market it expects this profit to dip further in FY2021 to just $560 million. That’s not enough to keep 2020’s dividend levels steady next year under this ‘75% payout ratio’ rule.

    However, AGL also told investors it would be bringing in a new rule for dividend payments for FY2021 and FY2022. This involves paying an additional 25% of profits as ‘special dividends’ on top of the normal 75%. In effect, this means AGL has committed to paying out 100% of its profits as dividends for the next two years. However, dividends won’t be coming with any franking credits at all over this period. This is being done so that AGL can “utilise historic tax losses”.

    So yes, it would appear that AGL is really offering a dividend yield of nearly 7.3% today, if the company’s guidance is anything to go by.

    These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)

    Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.

    Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.

    Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.

    Returns As of 6th October 2020

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Is AGL (ASX:AGL) really offering a 7% dividend yield today? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3gh3wD3

  • Telix (ASX:TLX) share price slips despite priority review status

    medical research

    The Telix Pharmaceuticals Ltd (ASX: TLX) share price is slipping today, down 2.5% in afternoon trading.

    This comes despite the company reporting it had received priority review status from Australia’s Therapeutic Goods Administration (TGA) for its prostate cancer imaging product, TLX591-CDx.

    The priority review provides Telix with a fast-tracked timeframe of 150 working days for its product dossier review and approval.

    It’s possible this news was already factored into the share price. Telix shares soared 121% higher in the month of November, and the share price is up 152% year-to-date. By comparison, the S&P/ASX 200 Index (ASX: XJO) is flat since 2 January.

    What does Telix Pharmaceuticals do?

    Telix Pharmaceuticals is a biopharmaceutical company focused on developing diagnostic and therapeutic products via molecularly targeted radiation (MTR). Based in Melbourne, Telix has international operations in Belgium, Japan and the United States.

    The company is currently developing a range of clinical-stage oncology products to address unmet medical needs involving prostate, kidney and brain cancers.

    What does the priority review status mean for Telix shares?

    Addressing the priority review status, Telix CEO Chris Behrenbruch said:

    As an Australian headquartered company, we are especially delighted that the TGA has granted Priority Review for TLX591-CDx, bringing us one step closer to providing a commercially available prostate imaging agent to patients in our own backyard.

    This is an important development for urologic oncology in Australia as a properly validated and commercially available product will ensure far greater patient access and confidence in the technology, currently only available on a limited basis under “special access” use from a relatively small number of academic nuclear medicine departments around the country.

    The company reported that its Medical Services Advisory Committee (MSAC) application is already in progress. In a forward-looking statement, it revealed that it expects that MSAC approval and commercial availability of TLX591-CDx around May or June of 2021, provided it receives the TGA approval.

    With prostate cancer killing 3,000 Aussie men each year (the second most common cause of cancer death), there are good reasons to hope Telix’s imaging product is successful beyond any share price gains.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Telix (ASX:TLX) share price slips despite priority review status appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3gion8U

  • Regional Express (ASX:REX) share price soars to 13-year high

    rising airline asx share price represented by boy playing with toy plane

    The Regional Express Holdings Ltd (ASX: REX) continued on its vertical ascend today with the stock hitting a 13-year high.

    The REX share price surged another 27.3% to $2.47 during lunch time trade when the S&P/ASX 200 Index (Index:^AXJO) inched up 0.3%.

    In contrast, the Qantas Airways Limited (ASX: QAN) share price jumped 3.1% to $5.44 and Alliance Aviation Services Ltd (ASX: AQZ) share price fell 2.1% to $3.82 at the time of writing.  

    Regional Express share price gets speeding ticket

    A number of positive tailwinds have pushed the Regional Express share price higher recently, including hopes of a COVID‐19 vaccine.

    But today’s big rise seems to have also baffled the airline after it was issued with a speeding ticket by ASX Ltd (ASX:ASX).

    Management offered a number of possible reasons for REX’s soaring share price.

    Rising confidence in REX share price

    The successful airfare promotion of $69 for a one-way trip between Melbourne and Sydney is one explanation. This could have lifted REX’s profile among the public and investors.

    Confidence in REX’s ability to transition to flying jets from propeller aircraft and launch a domestic service between major cities is touted as another potential driver for its share price.

    “The recognition by investors of Rex’s attractive lower cost structure relative to its competitors, including because, as reported recently in the press, Virgin has been unsuccessful in lowering its wage structure after negotiations with unions,” said REX.

    “The more positive general sentiment in the aviation sector due to the re-opening of domestic borders which has increased demand for passenger services with all airlines.”

    Finally, management acknowledged that day traders may also be contributing to the heightened volatility in the stock.

    How the REX share price is performing to the sector

    Regardless, REX’s shareholders are unlikely to be complaining as the Regional Express share price nearly doubled since the start of 2020.

    Not even the popular Qantas share price could keep up as the flying kangaroo crashed by more than 20% over the same period. The Sydney Airport Holdings Pty Ltd (ASX: SYD) share price is also down by a similar amount.

    The AQZ share price is doing better, but even than its 51% rise this year can’t keep pace with the REX share price.

    But Regional Express isn’t the only stock that looks well placed for 2021. The experts at the Motley Fool are bullish on the outlook of these other ASX stocks.

    Follow the link below to find out more.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Regional Express (ASX:REX) share price soars to 13-year high appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37JUGJQ

  • CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine

    vials of medication labelled with COVID-19 vaccine stickers

    The CSL Limited (ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.

    That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.

    With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.

    CSL and the University of Queensland (UQ) have been working collaboratively on a coronavirus vaccine since the outset of the pandemic.

    The sprint to the finish line looks to have been won by the mRNA vaccines developed by Moderna Inc (NASDAQ: MRNA), along with the partnered efforts of Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).

    But the experts at CSL and the UQ believe their own efforts may prove more valuable in the long run.

    More on that below. But first…

    What does CSL do?

    CSL is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines.

    CSL’s operational business segments include CSL Behring and Seqirus. The company operates predominantly in Australia, the United States, Germany, the United Kingdom and Switzerland.

    CSL shares first began trading on the ASX in 1994 and today it ranks among the largest companies on the ASX 200. At the current share price, CSL pays a 1% dividend yield, unfranked. The company paid out both dividends for 2020.

    Why could CSL’s COVID vaccine prove to be better?

    Professor Paul Young is the head of the UQ program developing a COVID vaccine together with CSL.

    Addressing their vaccine, Young said (as quoted by the Australian Financial Review):

    It is a more traditional vaccine. I think it will be a far more robust vaccine . . . and a better option for the long term. So I still think it’s an important vaccine even though we’re a little bit behind the mRNA vaccines.

    Data from the group’s phase 1 trial is expected soon, with phase 2 and 3 trials scheduled to commence in December. Young said if the trials are successful, their vaccine could be ready for wider use in Australia by mid-2021.

    Young also highlighted the historic shortage of medicinal manufacturing capabilities in Australia:

    Our sovereign capacity is not perhaps what it could have been. Our technology has led into CSL’s technology just beautifully. That was an excellent marriage. But, many of the other vaccine types that could have been developed in Australia haven’t been able to progress because there hasn’t been the infrastructure to take them into the next stage of development.

    Although CSL is working on other projects and has numerous successes under its belt, the pending success or failure of its COVID vaccine is likely to have a significant impact on its share price.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3mOZAMg